{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:44:29Z","timestamp":1767854669556,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ctrv.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T13:25:11Z","timestamp":1538745911000},"page":"76-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-7540","authenticated-orcid":false,"given":"Martina","family":"Imbimbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Ottaviano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Pasello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Perrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Schiavon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Pruneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo Paolo","family":"Dei Tos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Sangalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Chiara","family":"Garassino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Calareso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vieri","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-7140","authenticated-orcid":false,"given":"Lorenzo","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Giovanni","family":"Casali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5782-7717","authenticated-orcid":false,"given":"Sara","family":"Ramella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Abate-Daga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-9354","authenticated-orcid":false,"given":"Valter","family":"Torri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Trama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovannella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Alloisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Apolone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ardizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Benvenuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Buzzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Casadio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Cassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Caterino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Letizia","family":"Cecere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"De Braud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"De Pas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Lo Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spinelli","family":"Luisella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Luzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Marchian\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Margaritora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uliano","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Novellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Piras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Priola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Proto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Battista Ratto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavio","family":"Rena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Roca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Ruffini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiorgio","family":"Solli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Vespro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Zilembo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10 Suppl. 4","key":"10.1016\/j.ctrv.2018.10.001_b0005","first-page":"S260","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J ThoracOncol"},{"issue":"8","key":"10.1016\/j.ctrv.2018.10.001_b0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","article-title":"Burden and centralised treatment in Europe of raretumours: results of RARECAREnet-a population-based study","volume":"18","author":"Gatta","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson A. WHO classification of tumours of the lung, pleura, thymus and heart. Fourth edition - WHO classification of tumours, vol. 7, IARC Lyon 2015, ISBN 9789283224365."},{"key":"10.1016\/j.ctrv.2018.10.001_b0020","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2018.10.001_b0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and noninvasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"issue":"Suppl. 3","key":"10.1016\/j.ctrv.2018.10.001_b0030","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"9 Suppl. 2","key":"10.1016\/j.ctrv.2018.10.001_b0035","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","article-title":"The IASLC\/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Detterbeck","year":"2014","journal-title":"J Thor Oncol"},{"issue":"9 Suppl. 2","key":"10.1016\/j.ctrv.2018.10.001_b0040","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/JTO.0000000000000303","article-title":"The IASLC\/ITMIG thymic epithelial tumors staging project: proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Nicholson","year":"2014","journal-title":"J Thor Oncol"},{"issue":"9 Suppl. 2","key":"10.1016\/j.ctrv.2018.10.001_b0045","first-page":"S82","article-title":"The IASLC\/ITMIG thymic epithelial tumors staging project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Kondo","year":"2014","journal-title":"J Thor Oncol"},{"issue":"9 Suppl. 2","key":"10.1016\/j.ctrv.2018.10.001_b0050","first-page":"S90","article-title":"The ITMIG\/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification for malignant tumor","volume":"9","author":"Bhora","year":"2014","journal-title":"J Thor Oncol"},{"issue":"Suppl. 5","key":"10.1016\/j.ctrv.2018.10.001_b0055","doi-asserted-by":"crossref","first-page":"v40","DOI":"10.1093\/annonc\/mdv277","article-title":"Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Girard","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/JTO.0b013e3181a4b8e0","article-title":"The management of thymoma: a systematic review and practice guideline","volume":"4","author":"Falkson","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/JTO.0b013e31818e105c","article-title":"Thymoma: a focus on current therapeutic management","volume":"4","author":"Girard","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.ctrv.2018.10.001_b0070","doi-asserted-by":"crossref","first-page":"S1724","DOI":"10.1097\/JTO.0b013e31821ea57c","article-title":"Policies and reporting guidelines for small biopsy specimens of mediastinal masses","volume":"6","author":"Marchevsky","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.001_b0075","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/his.13099","article-title":"Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR) -","volume":"70","author":"Nicholson","year":"2017","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.001_b0080","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","article-title":"ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting","volume":"9","author":"Marx","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2018.10.001_b0085","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/JTO.0b013e3182a00f41","article-title":"NUT midline carcinoma: an aggressive intrathoracic neoplasm","volume":"8","author":"Parikh","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"7 Suppl. 3","key":"10.1016\/j.ctrv.2018.10.001_b0090","doi-asserted-by":"crossref","first-page":"S1730","DOI":"10.1097\/JTO.0b013e31821ea567","article-title":"Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J Thorac Oncol."},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.001_b0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00408-013-9465-5","article-title":"The impact of neoadjuvant chemotherapy on the histopathological assessment of thymomas: a clinicopathological correlation of 28 cases treated with a similar regimen","volume":"191","author":"Weissferdt","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.ctrv.2018.10.001_b0100","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/ejcts\/ezv426","article-title":"State of the art: diagnostic tools and innovative therapies for treatment of advanced thymoma and thymic carcinoma","volume":"49","author":"Ried","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.ctrv.2018.10.001_b0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumours","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctrv.2018.10.001_b0110","doi-asserted-by":"crossref","first-page":"AB003","DOI":"10.21037\/med.2017.AB003","article-title":"2017 TI - AB003. OS01.03. New proposed treatment for Pure Red Cell Aplasia Thymoma-related","volume":"1","author":"Palmieri","year":"2017","journal-title":"Mediastinum"},{"issue":"9 Suppl 2","key":"10.1016\/j.ctrv.2018.10.001_b0115","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/JTO.0000000000000300","article-title":"Paraneoplastic disorders in thymoma patients","volume":"9","author":"Evoli","year":"2014","journal-title":"J Thorac Oncol."},{"issue":"October","key":"10.1016\/j.ctrv.2018.10.001_b0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clim.2016.07.025","article-title":"Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective","volume":"171","author":"Jansen","year":"2016","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.001_b0125","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/039463201002300434","article-title":"Is hypogammaglobulinemia a constant feature in Good's syndrome?","volume":"23","author":"Federico","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"21","key":"10.1016\/j.ctrv.2018.10.001_b0130","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","article-title":"Pure red cell aplasia","volume":"128","author":"Means","year":"2016","journal-title":"Blood"},{"issue":"7 Suppl. 3","key":"10.1016\/j.ctrv.2018.10.001_b0135","doi-asserted-by":"crossref","first-page":"S1691","DOI":"10.1097\/JTO.0b013e3182254ac1","article-title":"Standard outcome measures for thymic malignancies","volume":"6","author":"Huang","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"7 Suppl 3","key":"10.1016\/j.ctrv.2018.10.001_b0140","doi-asserted-by":"crossref","first-page":"S1739","DOI":"10.1097\/JTO.0b013e31821ea553","article-title":"Standard terms, definitions, and policies for minimally invasive resection of thymoma","volume":"6","author":"Toker","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.001_b0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtho.2015.09.001","article-title":"Lymph node dissection in thymic malignancies: implication of the ITMIG lymph node map, TNM stage classification, and recommendations","volume":"11","author":"Hwang","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.001_b0150","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jtho.2017.01.002","article-title":"The impact of postoperative radiotherapy for thymoma and thymic carcinoma","volume":"12","author":"Jackson","year":"2017","journal-title":"J Thoracic Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2018.10.001_b0155","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2007.10.006","article-title":"Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection","volume":"71","author":"D'Angelillo","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"March","key":"10.1016\/j.ctrv.2018.10.001_b0160","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.001_b0165","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.athoracsur.2016.12.042","article-title":"A meta-analysis of postoperative radiotherapy for thymic carcinoma","volume":"103","author":"Hamaji","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.ctrv.2018.10.001_b0170","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jtho.2016.06.011","article-title":"Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma-an analysis of the international thymic malignancies interest group retrospective database","volume":"11","author":"Rimner","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.001_b0175","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2016.01.007","article-title":"Survival impact of adjuvant radiation therapy in Masaoka stage II to IV thymomas: a systematic review and meta-analysis","volume":"94","author":"Lim","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctrv.2018.10.001_b0180","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.001_b0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtcvs.2009.03.033","article-title":"Comparison of patterns of relapse in thymic carcinoma and thymoma","volume":"138","author":"Huang","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2018.10.001_b0190","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Thymic malignancies. V.2.2018. www.nccn.org [4 Nov 2017, date last accessed]."},{"key":"10.1016\/j.ctrv.2018.10.001_b0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/JTO.0b013e31818e105c","article-title":"Thymoma: a focus on current therapeutic management","volume":"4","author":"Girard","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"7 Suppl 3","key":"10.1016\/j.ctrv.2018.10.001_b0200","doi-asserted-by":"crossref","first-page":"S1749","DOI":"10.1097\/JTO.0b013e31821ea5f7","article-title":"Chemotherapy definitions and policies for thymic malignancies","volume":"6","author":"Girard","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0205","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/era.12.29","article-title":"Chemotherapy and targeted agents for thymic malignancies","volume":"12","author":"Girard","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ctrv.2018.10.001_b0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2152\/jmi.55.17","article-title":"Optimal therapy for thymoma","volume":"55","author":"Kondo","year":"2008","journal-title":"J Med Invest"},{"key":"10.1016\/j.ctrv.2018.10.001_b0215","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00432-014-1800-6","article-title":"Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy","volume":"141","author":"Okuma","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thorsurg.2010.08.003","article-title":"Chemotherapy for thymic tumors: induction, consolidation, palliation","volume":"21","author":"Rajan","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.ctrv.2018.10.001_b0225","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1097\/JTO.0b013e3181f21129","article-title":"The role of chemotherapy in advanced thymoma","volume":"5","author":"Schmitt","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0230","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtcvs.2013.08.061","article-title":"Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial","volume":"147","author":"Korst","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2018.10.001_b0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","article-title":"Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors","volume":"85","author":"Wright","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.ctrv.2018.10.001_b0245","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0250","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/annonc\/mdu541","article-title":"A multicentre phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L","volume":"26","author":"Hirai","year":"2015","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2018.10.001_b0255","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone","year":"1996","journal-title":"J Clin Oncol."},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.001_b0260","first-page":"2023","article-title":"A pilot study of cisplatin and etoposide with and without radiotherapy for advanced malignant thymoma","volume":"34","author":"Tamiya","year":"2014","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.ctrv.2018.10.001_b0265","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/CCO.0000000000000355","article-title":"Systemic treatment for thymic malignancies","volume":"29","author":"Girard","year":"2017","journal-title":"Curr Opin Oncol"},{"issue":"11S212","key":"10.1016\/j.ctrv.2018.10.001_b0270","first-page":"2","article-title":"Platinum rechallenge in advanced thymic epithelial tumors: still an option in the age of target therapy? A monocentric experience","volume":"12","author":"Ottaviano","year":"2017","journal-title":"J Thoracic Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0275","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1378\/chest.110.4.1115","article-title":"Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide","volume":"110","author":"Lara","year":"1996","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ctrv.2018.10.001_b0280","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/annonc\/mdp483","article-title":"Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)","volume":"21","author":"Palmieri","year":"2010","journal-title":"Ann Oncol"},{"issue":"14","key":"10.1016\/j.ctrv.2018.10.001_b0285","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2217\/fon.14.144","article-title":"Capecitabine plus gemcitabine in thymic epithelial tumors final analysis of a Phase II trial","volume":"10","author":"Palmieri","year":"2014","journal-title":"Future Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.ctrv.2018.10.001_b0290","first-page":"80","article-title":"Role of somatostatin analogue-based therapy in unresponsive malignant thymomas","volume":"31","author":"Palmieri","year":"1999","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.001_b0295","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/cncr.10374","article-title":"Somatostatin analogs and prednisone in advanced refractory thymic tumors","volume":"94","author":"Palmieri","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2018.10.001_b0300","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.7582","article-title":"Effectiveness of somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors","volume":"33","author":"Ottaviano","year":"2015","journal-title":"J Clin Oncol"},{"issue":"September","key":"10.1016\/j.ctrv.2018.10.001_b0305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lungcan.2016.06.020","article-title":"Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience","volume":"99","author":"Bluthgen","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctrv.2018.10.001_b0310","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.e20112","article-title":"Effectiveness of cytotoxic agent etoposide after biological therapy in advanced thymic tumours","volume":"34","author":"Damiano","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0315","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ctrv.2018.10.001_b0320","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial","volume":"16","author":"Thomas","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.001_b0325","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1016\/j.cllc.2018.06.005","article-title":"RELEVENT trial: phase II trial of ramucirumab, carboplatin, and paclitaxel in previously untreated thymic carcinoma\/B3 thymoma with area of carcinoma","volume":"19","author":"Imbimbo","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ctrv.2018.10.001_b0330","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/JTO.0b013e3181e96e30","article-title":"Expression and mutational status of c-kit in thymic epithelial tumors","volume":"5","author":"Petrini","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"25","key":"10.1016\/j.ctrv.2018.10.001_b0335","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Str\u00f6bel","year":"2004","journal-title":"N Engl J Med"},{"issue":"33","key":"10.1016\/j.ctrv.2018.10.001_b0340","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1200\/JCO.2011.36.6427","article-title":"Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma","volume":"29","author":"Buti","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2018.10.001_b0345","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3892\/mco.2016.752","article-title":"c-kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: a case report","volume":"4","author":"Hirai","year":"2016","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2018.10.001_b0350","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/JTO.0b013e3182a7d22e","article-title":"Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing","volume":"9","author":"Hagemann","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ctrv.2018.10.001_b0355","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.8573","article-title":"Pembrolizumab in patients with recurrent thymic carcinoma: results of a phase II study","volume":"35","author":"Giaccone","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.001_b0360","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2017.74.4078","article-title":"Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy","volume":"36","author":"Zucali","year":"2018","journal-title":"J Clin Oncol"},{"issue":"February","key":"10.1016\/j.ctrv.2018.10.001_b0365","article-title":"Mesothelioma and thymic tumors: treatment challenges in (outside) a network setting","author":"Imbimbo","year":"2018","journal-title":"Eur J Surg Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737218301634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737218301634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T09:21:04Z","timestamp":1759656064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737218301634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":73,"alternative-id":["S0305737218301634"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2018.10.001","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}